Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients

Chemistry and Physics of Lipids

Volumn 91, Issue 1, 1997, Pages 1-11

  Jira, Wolfgang ^a   Spiteller, Gerhard ^a   Carson, Walter ^b   Schramm, Axel ^b  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

13 HODE; 9 HODE; Atherosclerosis; LDL; Linoleic acid; Lipid peroxidation

Indexed keywords

HYDROXY FATTY ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID COMPOSITION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; VOLUNTEER;

ADULT; ARTERIOSCLEROSIS; FEMALE; HUMANS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; ULTRASONOGRAPHY;

EID: 0342757728     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(97)00095-9     Document Type: Article

References (46)

1. Aznar J., Santos M.T., Valles J., Sala J. Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction. J. Clin. Pathol. 36:1983;712-715.
2. Belkner J., Wiesner R., Kuehn H. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase. FEBS Lett. 279(1):1991;110-114.
3. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med. 20(5):1996;707-727.
4. Blake, D.R., Lunec, J., 1990. In: Cohen, R.D., Alberti, K.G.M.M., Lewis, B., Denman, A.M. (Eds.), The metabolic and molecular basis of acquired disease, vol. XX, Bailliere Tindall, London, pp. 189-212.
5. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
6. Brooks C.J.W., Harland W.A., Steel G., Gilbert J.D. Lipids of human atheroma: Isolation of hydroxyoctadecadienoic acids from advanced aortal lesions. Biochim. Biophys. Acta. 202:1970;563-566.
7. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
8. Dudda A., Spiteller G., Kobelt F. Lipid oxidation products in ischemic porcine heart tissue. Chem. Phys. Lipids. 82:1996;39-51.
9. Esterbauer H., Gebicki J., Puhl H., Juergens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13(4):1992;341-390.
10. Esterbauer H., Rotheneder M., Striegl G., Waeg G., Ashy A., Sattler W., Juergens G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation Fett Wiss. Technol. 91(8):1989;316-324.
11. Gey K.F. On the antioxidant hypothesis with regard to arteriosclerosis. Bibliotheca Nutritio et Dieta. 37:1986;53-91.
12. Glavind J., Hartman S., Clemmesen J., Jessen K.E., Dam H. Studies on the role of lipoperoxides in human pathology II. The presence of peroxidized lipids in the atherosclerotic aorta. Acta Pathol. Microbiol. Scand. 30:1952;1-6.
13. Goldstein J.L., Brown M.S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46:1977;897-930.
14. Goto, Y., 1982. In: Yagi, K. (Ed.), Lipid peroxides in biology and medicine, Academic Press, San Diego, S.295.
15. Gotto, A.M., 1987. Plasma Lipoproteins, Elsevier, Amsterdam.
16. Hagihara M., Nishagaki I., Maseki M., Yagi K. Age-dependent changes in lipid peroxide levels in the lipoprotein fractions of human serum. J. Gerontol. 39:1984;269-272.
17. Halliwell B., Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213(1):1987;9-14.
18. Halliwell B., Gutteridge J.M.C. Biologically relevant metal ion-dependent hydroxyl radical generation, an update. FEBS Lett. 307(1):1992;108-112.
19. Hartmann, S., Glavind, J., 1949. A new sensitive method for the determination of peroxides of fats and fatty acids. Acta chem. Scand. 3, 954-958.
20. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74(5):1984;1890-1894.
21. Jackson R.L., Ku G., Thomas C.E. Antioxidants: a biological defense mechanism for the prevention of atherosclerosis. Med. Res. Rev. 13(2):1993;161-182.
22. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indexes of lipid peroxidation and peroxidative tissue injury. Free Radical Biol. Med. 9(6):1990;515-540.
23. Jeny C., Goy J., Fechner J., Loeper J. Study of lipid peroxidation in human and experimental atheroma by measurements of plasma malondialdehyde. Presse Med. 15:1986;1131-1133.
24. Jira W., Spiteller G. Plasmalogens and their oxidative degradation products in low and high density lipoproteins. Chem. Phys. Lipids. 79:1996;95-100.
25. Jira, W., Spiteller, G., Richter, A., 1997. Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem. Phys. Lipids 87, 81-89.
26. Jira W., Spiteller G., Schramm A. Increase in hydroxy fatty acids in human low density lipoproteins with age. Chem. Phys. Lipids. 84:1996;165-173.
27. Kaduce T.L., Figard P.H., Leifur R., Spector A.A. Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J. Biol. Chem. 264(12):1989;6823-6830.
28. Ku G., Thomas C.E., Akeson A.L., Jackson R.L. Induction of interleukin 1.beta. expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid J. Biol. Chem. 267(20):1992;14183-14188.
29. Ledwozyw A., Michalak J., Stepien A., Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta. 155:1986;275-283.
30. Lehmann W.D., Stephan M., Fuerstenberger G. Profiling assay for lipoxygenase products of linoleic and arachidonic acid by gas chromatography-mass spectrometry. Anal. Biochem. 204(1):1992;158-170.
31. Leiss O., Murawski U., Egge H. The microanalysis of serum lipoprotein lipids. J. Clin. Chem. Clin. Biochem. 17(10):1979;619-625.
32. Miyazawa T. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radical Biol. Med. 7(2):1989;209-217.
33. Miyazawa T., Fujimoto K., Oikawa S. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection. Biomed. Chromatogr. 4(3):1990;131-134.
34. Miyazawa T., Yasuda K., Fujimoto K. Presence of phosphatidylcholine hydroperoxide in human plasma. J. Biochem. (Tokyo). 103(5):1988;744-746.
35. Moch D., Schewe T., Kuehn H., Schmidt D., Buntrock P. The linoleic acid metabolite 9Ds-hydroxy-10,12(E,Z)-octadecadienoic acid is a strong proinflammatory mediator in an experimental wound healing model of the rat. Biomed. Biochim. Acta. 49:1990;201-207.
36. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Atherosclerosis. 4:1984;357-364.
37. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta. 90:1978;37-43.
38. Schimke I., Kahl P.E., Romaniuk P., Papies B. Konzentration Thiobarbitursäure-reaktiver Substanzen (TBARS) im Serum nach Myokardinfarkt. Klin. Wochenschr. 64:1986;1237-1239.
39. Spiteller, P., Spiteller, G., 1997. 9-Hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE) - excellent markers for lipid peroxidation. Chem. Phys. Lipids 89, 131-139.
40. Steinbrecher U.P., Parthasarathy M., Leake D.S., Witztum J.L., Steinberg D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81(12):1984;3883-3887.
41. Stringer M.D., Görög P.G., Freeman A., Kakkar V.V. Lipid peroxides and atherosclerosis. Br. J. Med. 298:1989;281-284.
42. Szczeklik A., Gryglewski R.J. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery. 7:1980;488-495.
43. VanKuijk F.J.G.M., Sevanian A., Handelman G.J., Dratz E.A. A new role for phospholipase A2: protection of membranes from lipid peroxidation damage. TIBS. 12:1987;31-34.
44. Wang T., Powell W.S. Increased levels of monohydroxy metabolites of arachidonic acid and linoleic acid in LDL and aorta from atherosclerotic rabbits. Biochim. Biophys. Acta. 1084(2):1991;129-138.
45. Weisser B., Locher R., Mengden T., Sachinidis A., Vetter W. Oxidized low-density lipoproteins in atherogenesis: possible mechanisms of action. J. Cardiovasc. Pharmacol. 19:1992;4-7.
46. Yalcin A.S., Sabuncu N., Kilinc A., Gülcan G., Emerk K. Increased plasma and erythrocyte lipid peroxidation in hyperlipidemic individuals. Atherosclerosis. 80:1989;169-170.